137 related articles for article (PubMed ID: 35494967)
1. Post-vaccination Adverse Reactions After Receiving the Pfizer-BioNTech Coronavirus Disease 2019 Vaccines Among Healthcare Workers in Sapporo, Japan.
Shimamura Y; Anbo Y; Furuta Y
Cureus; 2022 Mar; 14(3):e23549. PubMed ID: 35494967
[TBL] [Abstract][Full Text] [Related]
2. Adverse reactions to the first and second doses of Pfizer-BioNTech COVID-19 vaccine among healthcare workers.
Maruyama A; Sawa T; Teramukai S; Katoh N
J Infect Chemother; 2022 Jul; 28(7):934-942. PubMed ID: 35361536
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
4. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.
;
MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297
[TBL] [Abstract][Full Text] [Related]
5. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022.
Hause AM; Baggs J; Marquez P; Abara WE; Olubajo B; Myers TR; Su JR; Thompson D; Gee J; Shimabukuro TT; Shay DK
MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(9):347-351. PubMed ID: 35239637
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021.
Hause AM; Baggs J; Marquez P; Myers TR; Gee J; Su JR; Zhang B; Thompson D; Shimabukuro TT; Shay DK
MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(5152):1755-1760. PubMed ID: 34968370
[TBL] [Abstract][Full Text] [Related]
7. Adverse Events and Immunogenicity of mRNA-Based COVID-19 Vaccine among Healthcare Workers: A Single-Centre Experience.
Sauserienė J; Liseckienė I; Neverauskė V; Šepetauskienė E; Serapinas D; Mačinskas Š; Šitkauskienė B; Bajoriūnienė I; Vaičiūnienė R; Valius L
Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334616
[No Abstract] [Full Text] [Related]
8. The Adverse Reactions of Pfizer BioNTech COVID-19 Vaccine Booster Dose are Mild and Similar to the Second Dose Responses: A Retrospective Cross-Sectional Study.
El-Shitany NA; Bagher AM; Binmahfouz LS; Eid BG; Almukadi H; Badr-Eldin SM; El-Hamamsy M; Mohammedsaleh ZM; Saleh FM; Almuhayawi MS; Alghamdi SA; Arab RA; Ali SS; Harakeh S; Alghamdi BS
Int J Gen Med; 2022; 15():6821-6836. PubMed ID: 36051568
[TBL] [Abstract][Full Text] [Related]
9. Adverse reactions following COVID-19 vaccination: An Ecuadorian experience.
Vanegas E; Robles-Velasco K; Osorio MF; Farfán Bajaña MJ; Sarfraz Z; Sarfraz A; Fernández Cadena JC; Andrade Molina DM; Panchana Lascano M; Cherrez-Ojeda I
Ann Med Surg (Lond); 2021 Dec; 72():103044. PubMed ID: 34812287
[TBL] [Abstract][Full Text] [Related]
10. Qualitative Assessment of Early Adverse Effects of Pfizer-BioNTech and Sinopharm COVID-19 Vaccines by Telephone Interviews.
Abu-Halaweh S; Alqassieh R; Suleiman A; Al-Sabbagh MQ; AbuHalaweh M; AlKhader D; Abu-Nejem R; Nabulsi R; Al-Tamimi M; Alwreikat M; Alnouti M; Suleiman B; Yousef M; Jarbeh ME; Al-Shudifat AE; Alqassieh A; Bsisu I
Vaccines (Basel); 2021 Aug; 9(9):. PubMed ID: 34579187
[TBL] [Abstract][Full Text] [Related]
11. Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.
Hause AM; Baggs J; Gee J; Marquez P; Myers TR; Shimabukuro TT; Shay DK
MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(39):1379-1384. PubMed ID: 34591835
[TBL] [Abstract][Full Text] [Related]
12. Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report.
Iguchi T; Umeda H; Kojima M; Kanno Y; Tanaka Y; Kinoshita N; Sato D
Drug Saf; 2021 Nov; 44(11):1209-1214. PubMed ID: 34347278
[TBL] [Abstract][Full Text] [Related]
13. First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021.
Gee J; Marquez P; Su J; Calvert GM; Liu R; Myers T; Nair N; Martin S; Clark T; Markowitz L; Lindsey N; Zhang B; Licata C; Jazwa A; Sotir M; Shimabukuro T
MMWR Morb Mortal Wkly Rep; 2021 Feb; 70(8):283-288. PubMed ID: 33630816
[TBL] [Abstract][Full Text] [Related]
14. Adverse Events with the Pfizer-BioNTech COVID-19 Vaccine among Korean Healthcare Workers.
Im JH; Kim E; Lee E; Seo Y; Lee Y; Jang Y; Yu S; Maeng Y; Park S; Park S; Kim J; Lee JS; Baek JH
Yonsei Med J; 2021 Dec; 62(12):1162-1168. PubMed ID: 34816647
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
16. Suspected Anaphylactic Reaction Following Second Dose of the Pfizer-BioNTech (BNT162b2) Coronavirus Vaccine in a Geriatric Female.
Hong A; Sardinas G
HCA Healthc J Med; 2022; 3(6):349-354. PubMed ID: 37427315
[TBL] [Abstract][Full Text] [Related]
17. Reactogenicity following two doses of the BNT162b2 mRNA COVID-19 vaccine: Real-world evidence from healthcare workers in Japan.
Saita M; Yan Y; Ito K; Sasano H; Seyama K; Naito T
J Infect Chemother; 2022 Jan; 28(1):116-119. PubMed ID: 34580011
[TBL] [Abstract][Full Text] [Related]
18. The Effectiveness of Paracetamol to Reduce the Post-Vaccination SARS-CoV-2 Adverse Effects in an Italian Vaccination Center.
Ricci E; Glavasc A; Morandini B; Grassi MC; La Torre G
Vaccines (Basel); 2023 Sep; 11(9):. PubMed ID: 37766169
[TBL] [Abstract][Full Text] [Related]
19. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
Hause AM; Baggs J; Marquez P; Myers TR; Su JR; Blanc PG; Gwira Baumblatt JA; Woo EJ; Gee J; Shimabukuro TT; Shay DK
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):249-254. PubMed ID: 35176008
[TBL] [Abstract][Full Text] [Related]
20. Safety and side effect profile of Pfizer-BioNTech COVID-19 vaccination among healthcare workers: A tertiary hospital experience in Singapore.
Lim SM; Chan HC; Santosa A; Quek SC; Liu EHC; Somani J
Ann Acad Med Singap; 2021 Sep; 50(9):703-711. PubMed ID: 34625758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
